Cooper v Goldfarb
|
154 F3d 1321
|
United States Court of Appeals, Federal Circuit
|
United States
|
1 Sep 1998
|
WorldLII
|
|
21
|
Burroughs Wellcome Co v Barr Laboratories, Inc
|
40 F3d 1223; 32 USPQ2d 1915
|
|
United States
|
circa 1915
|
Westlaw
|
|
38
|
Knorr v Pearson
|
671 F2d 1368; (1375) 213 USPQ 196; (1374) 213 USPQ2d 196
|
|
United States
|
circa 1915
|
Westlaw
|
|
11
|
Similarly, Langer v Kaufman
|
465 F2d 915; 59 CCPA 1261; 175 USPQ 172
|
|
United States
|
circa 1915
|
Westlaw
|
|
5
|
Heard v Burton
|
333 F2d 239; 51 CCPA 1502; 142 USPQ 97
|
|
United States
|
circa 1915
|
Westlaw
|
|
10
|
Gianladis v Kass
|
324 F2d 322; 139 USPQ 300; 51 CCPA 753
|
|
United States
|
circa 1915
|
Westlaw
|
|
4
|
Genentech, Inc v Chiron Corporation
|
220 F3d 1345; (1351) 55 USPQ2d 1636
|
|
United States
|
circa 1915
|
Westlaw
|
|
1
|
35 USC 1295
|
35 USC 1295
|
United States Code
|
United States
|
circa 1915
|
LII (Cornell)
|
|
2
|
US Patent and Trademark Office, Guidelines Concerning the Implementation of Changes to
|
35 USC 102
|
United States Code
|
United States
|
|
LII (Cornell)
|
|
446
|